HY-100272-1mg
|
MedChemexpress LLC
|
B220 [CAS 112228-65-6]
|
|
Cancer-programmed cell death
|
|
HY-100369A-10mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-100mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-25mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-5mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-100369A-50mg
|
MedChemexpress LLC
|
DMCM (hydrochloride) [CAS 1215833-62-7]
|
|
Cancer-programmed cell death
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-50mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-100370-10mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100370-5mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100370-50mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
HY-100402-10mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-100mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-25mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-5mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100402-50mg
|
MedChemexpress LLC
|
CFMTI [CAS 864864-17-5]
|
|
Cancer-programmed cell death
|
|
HY-100483-1mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-10mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-100mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-25mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-5mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-50mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100488-10mg
|
MedChemexpress LLC
|
Bay 59-3074 [CAS 406205-74-1]
|
|
Cancer-programmed cell death
|
|